Multiple myeloma – bortezomib Continuing PBS authority application Supporting information form (PB102)

You must lodge this form for a patient continuing Pharmaceutical Benefits Scheme (PBS) subsidised treatment with bortezomib for multiple myeloma.


Page last updated: 13 July 2016

This information was printed Tuesday 27 September 2016 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.